Ignite Creation Date:
2024-05-06 @ 7:00 PM
Last Modification Date:
2024-10-26 @ 2:59 PM
Study NCT ID:
NCT05868265
Status:
RECRUITING
Last Update Posted:
2024-04-12
First Post:
2023-05-11
Brief Title:
A Study of Enfortumab Vedotin in People With Urothelial Carcinoma of the Upper Urinary Tract
Sponsor:
Memorial Sloan Kettering Cancer Center
Organization:
Memorial Sloan Kettering Cancer Center
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-06-02
Start Date Type:
ACTUAL
Primary Completion Date:
2025-05
Primary Completion Date Type:
ESTIMATED
Completion Date:
2025-05
Completion Date Type:
ESTIMATED
First Submit Date:
2023-05-11
First Submit QC Date:
May 11 2023
Study First Post Date:
2023-05-22
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-08-15
Last Update Post Date:
2024-04-12
Last Update Post Date Type:
ACTUAL